May 7, 2007
India’s biotechnology industry has the potential to become a major driver of the country’s economy, but is challenged by one vital omission: patent protection. While current patent laws support a strong Indian generic industry, they also impede foreign investment. Without foreign investment India loses trading opportunities, and without a capacity to produce branded drugs India [...]
Read the full article →
May 1, 2007
Courtesy of DrugPatentWatch.com: Drug Patent Expirations in May 2007*Drugs may be covered by more than one patent Tradename Applicant Generic Name Patent Number Patent Expiration DIPROLENE Schering betamethasone dipropionate 4,775,529 MAY 21,2007 HABITROL Novartis nicotine 5,834,011 MAY 01,2007 OMNISCAN Ge Healthcare gadodiamide 4,687,659 MAY 04,2007 PATANOL Alcon olopatadine hydrochloride 4,923,892 MAY 08,2007 RANEXA Cv Therap [...]
Read the full article →